title: Doxorubicin in relapsed soft tissue sarcoma: justification of phase II evaluation of new drugs in this disease. An EORTC Soft Tissue and Bone Sarcoma Group Study.
authors: Department of Medicine, Queen Elizabeth Hospital, Birmingham, U.K.
authors: G
authors: G
authors: Blackledge
authors: A
authors: A
authors: van Oosterom
authors: H
authors: H
authors: Mouridsen
authors: W P
authors: WP
authors: Steward
authors: J
authors: J
authors: Buesa
authors: D
authors: D
authors: Thomas
authors: R
authors: R
authors: Sylvester
authors: J
authors: J
authors: Rouesse
mesh_terms: D000328:Adult; D004317:Doxorubicin / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012509:Sarcoma / Q000188:drug therapy*; D012983:Soft Tissue Neoplasms / Q000188:drug therapy*
chemical_list: D004317:Doxorubicin